JP Morgan Chase’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,003,617
| Closed | -$5.58M | – | 7775 |
|
|
2024
Q2 | $5.58M | Buy |
1,003,617
+981,482
| +4,434% | +$3.49M | ﹤0.01% | 2955 |
|
|
2024
Q1 | $86.3K | Buy |
22,135
+22,074
| +36,187% | +$84K | ﹤0.01% | 5740 |
|
|
2023
Q4 | $263 | Sell |
61
-4,679
| -99% | -$15.8K | ﹤0.01% | 7021 |
|
|
2023
Q3 | $14.7K | Sell |
4,740
-612
| -11% | -$2.02K | ﹤0.01% | 6152 |
|
|
2023
Q2 | $15.6K | Sell |
5,352
-5,012
| -48% | -$11.5K | ﹤0.01% | 5974 |
|
|
2023
Q1 | $21K | Buy |
10,364
+9,838
| +1,870% | +$22.9K | ﹤0.01% | 5969 |
|
|
2022
Q4 | $1K | Buy |
+526
| New | +$2.24K | ﹤0.01% | 6465 |
|
|
2022
Q3 | – | Sell |
-2,198
| Closed | -$12K | – | 6958 |
|
|
2022
Q2 | $12K | Sell |
2,198
-1,076
| -33% | -$5.92K | ﹤0.01% | 6005 |
|
|
2022
Q1 | $18K | Sell |
3,274
-1,330
| -29% | -$6.48K | ﹤0.01% | 6092 |
|
|
2021
Q4 | $24K | Sell |
4,604
-19,157
| -81% | -$93.8K | ﹤0.01% | 6173 |
|
|
2021
Q3 | $101K | Buy |
+23,761
| New | +$166K | ﹤0.01% | 5562 |
|
|
2018
Q1 | – | Sell |
-540
| Closed | -$11K | – | 5681 |
|
|
2017
Q4 | $11K | Sell |
540
-1,293
| -71% | -$25.2K | ﹤0.01% | 5258 |
|
|
2017
Q3 | $37K | Buy |
1,833
+893
| +95% | +$19.1K | ﹤0.01% | 4530 |
|
|
2017
Q2 | $20K | Buy |
+940
| New | +$20.1K | ﹤0.01% | 4543 |
|
|
2017
Q1 | – | Sell |
-73
| Closed | -$1K | – | 5276 |
|
|
2016
Q4 | $1K | Sell |
73
-5
| -6% | -$92 | ﹤0.01% | 4966 |
|
|
2016
Q3 | $2K | Sell |
78
-75
| -49% | -$1.73K | ﹤0.01% | 4446 |
|
|
2016
Q2 | $2K | Sell |
153
-40
| -21% | -$1.06K | ﹤0.01% | 4619 |
|
|
2016
Q1 | $5K | Sell |
193
-40
| -17% | -$1.25K | ﹤0.01% | 4379 |
|
|
2015
Q4 | $8K | Buy |
+233
| New | +$10.1K | ﹤0.01% | 4259 |
|
|
2015
Q1 | – | Sell |
-5,919
| Closed | -$492K | – | 4310 |
|
|
2014
Q4 | $492K | Buy |
+5,919
| New | +$480K | ﹤0.01% | 3674 |
|
|
2013
Q3 | – | Sell |
-822
| Closed | -$60K | – | 4476 |
|
|
2013
Q2 | $60K | Buy |
+822
| New | +$47.4K | ﹤0.01% | 4250 |
|
JP Morgan Chase's ALIM Position: Q3 2024 in Review
JP Morgan Chase sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 1,003,617 shares — an estimated $5.58M sold.
JP Morgan Chase first reported a position in ALIM in Q2 2013 and held it in 21 quarters. The position peaked at $5.58M in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- JP Morgan Chase reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- JP Morgan Chase sold 1,003,617 Alimera Sciences shares in Q3 2024, an estimated $5.58M.
- JP Morgan Chase first reported a position in Alimera Sciences in Q2 2013 and held it in 21 quarters.
- JP Morgan Chase's Alimera Sciences position peaked at $5.58M in Q2 2024.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.